Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Colorado Springs. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Colorado Springs at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
The goal of this clinical trial is to evaluate the efficacy, safety and pharmacokinetics of elamipretide in subjects with dry age-related macular degeneration (AMD). The main questions it aims to answer are: what is the rate of change in the macular area of photoreceptor loss in subjects who receive a daily dose of elamipretide compared with those who receive a look-alike substance that contains no active drug, and what is the safety and tolerability of elamipretide daily subcutaneous injections
Sponsor: Stealth BioTherapeutics Inc.
Check if you qualify for this macular degeneration clinical trial in Colorado Springs, CO
If you're searching for macular degeneration treatment options in Colorado Springs, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Colorado Springs research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.